Newsroom

Sorted by: Latest

-

Palantir to Deliver Eight TITAN Systems to the U.S. Army

MIAMI--(BUSINESS WIRE)--Palantir Technologies Inc. (NASDAQ: PLTR) today announced that the Army Contracting Command has awarded Palantir USG, Inc. — a wholly-owned subsidiary of Palantir Technologies Inc. — a prime agreement for the production and delivery of the Tactical Intelligence Targeting Access Node (TITAN) ground station system, the Army’s next-generation deep-sensing capability enabled by artificial intelligence and machine learning. The agreement covers the production of eight new TIT...
-

NeuroPace to Participate in 2026 Cantor Global Healthcare Conference

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management team will participate in the upcoming 2026 Cantor Global Healthcare Conference. NeuroPace management will participate in a fireside chat discussion on Wednesday, September 9 at 10:55am EDT, and host one-on-one meetings with investors during the conference. The fireside chat will be accessible via a...
-

CMS Approves New Technology Add-on Payment for Reflow Medical’s Spur® Peripheral Retrievable Stent System

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Reflow Medical, Inc. announced that the Centers for Medicare & Medicaid Services (CMS) has granted the Spur Peripheral Retrievable Stent System a New Technology Add-on Payment (NTAP), providing additional reimbursement for eligible Fee-for-Service Medicare inpatient cases beginning October 1, 2026. Under the Fiscal Year 2027 NTAP program, qualifying inpatient cases involving the Spur Stent System are eligible for an incremental payment up to $2,596.75,...
-

Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)--Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha Cognition”, “ACI”, or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today announced that on August 31st, 2026, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) granted inducement awards consisting of nonstatutory stock options to purchase 20,000 shares of common stock to...
-

DigitalBridge Announces Intention to Voluntarily Delist Preferred Stock from the NYSE

BOCA RATON, Fla.--(BUSINESS WIRE)--DigitalBridge Group, Inc. (NYSE: DBRG) (the “Company” or “DigitalBridge”), publicly announced today, in connection with its anticipated acquisition by an affiliate of SoftBank Group Corp. (TSE: 9984, “SoftBank Group”), that it intends to voluntarily withdraw from listing on the New York Stock Exchange (the “NYSE”) and registration under Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Company’s (i) 7.125% Series H Cumul...
-

CORRECTING and REPLACING Waites Strengthens Enterprise Reliability and AI Prescriptive Maintenance Solutions to Optimize Overall Equipment Effectiveness

CINCINNATI--(BUSINESS WIRE)--Waites announced expanded technology capabilities and solutions to support manufacturing teams in optimizing OEE in the mission to eliminate downtime....
-

Dhruvaتمنح علامتها التجارية اسمًا جديدًا، Ryan، في جميع أنحاء الشرق الأوسط، من أجل علامة تجارية عالمية موحدة

دبي، الإمارات العربية المتحدة، والرياض، المملكة العربية السعودية--(BUSINESS WIRE)--أعلنت اليوم Dhruva، وهي شركة استشارات ضريبية رائدة في الشرق الأوسط، وRyan، وهي مزود عالمي رائد للخدمات والبرمجيات الضريبية، عن انتقال Dhruva إلى العلامة التجارية لشركة Ryan في جميع أنحاء الإمارات العربية المتحدة والمملكة العربية السعودية. ومن المتوقع اكتمال عملية إعادة تسمية العلامة التجارية بحلول نهاية عام 2026، مما يضع أعمال الشركة تحت الهوية العالمية لشركة Ryan، ويعزز مكانتها كجزء من المتخصصين الرائدين عالمياً...
-

Virtus Dividend, Interest & Premium Strategy Fund Announces Commencement of Tender Offer

HARTFORD, Conn.--(BUSINESS WIRE)--Virtus Dividend, Interest & Premium Strategy Fund (NYSE: NFJ) (the “Fund”) today announced the commencement of a tender offer (“Tender Offer”) beginning September 1, 2026, and expiring at 5:00 p.m. (Eastern) on October 5, 2026, unless the Tender Offer is extended (the “Expiration Date”).The Fund, as announced on April 17, 2026, is offering to acquire up to 25% of its outstanding common shares in exchange for cash at a price equal to 99% of the Fund’s net ass...
-

Styx Biotechnologies Announces Strategic Agreement with ZoeNCure Therapeutics to Accelerate Next-Generation ADC Pipeline to Clinic

SAN DIEGO--(BUSINESS WIRE)--Styx Biotechnologies, Inc., a San Diego-based biotechnology company developing next-generation antibody-drug conjugates (ADCs) for solid tumors, today announced a strategic agreement with ZoeNCure Therapeutics Pvt. Ltd. to accelerate selected Styx ADC programs toward first-in-human clinical studies. Under the agreement, Styx will receive an upfront payment and additional milestone-based payments tied to development progress. In exchange, ZoeNCure will provide develop...
-

ChargePoint accelera la strategia di crescita europea con la nomina di John Saffrett in qualità di EVP e Direttore generale per l'Europa

CAMPBELL, California--(BUSINESS WIRE)--ChargePoint (NYSE: CHPT), leader globale nell'elettrificazione intelligente e nella mobilità elettrica, ha annunciato oggi la nomina di John Saffrett in qualità di Vicepresidente esecutivo (EVP) e direttore generale (MD) per l'Europa. In tale ruolo, Saffrett sarà responsabile della guida della strategia di crescita di ChargePoint nei mercati europei, supervisionando le vendite, le relazioni con i clienti, le partnership e l'espansione di mercato nel contin...